What is the next step in managing a 75‑year‑old man with a blood pressure of 160/80 who is taking amlodipine, aspirin 81 mg, ezetimibe, buspirone, clonazepam, duloxetine, epinephrine, metformin, silodosin, trazodone, bupropion, atorvastatin, and trospium?

Management of Uncontrolled Hypertension in a 75-Year-Old Male on Amlodipine Monotherapy

Add a thiazide or thiazide-like diuretic (such as chlorthalidone or hydrochlorothiazide) to the current amlodipine 10 mg regimen immediately, as this patient has Grade 2 hypertension (160/80 mmHg) with diabetes mellitus requiring prompt intensification of therapy. 1

Rationale for Immediate Treatment Intensification

This patient meets criteria for urgent blood pressure escalation based on multiple factors:

• Grade 2 hypertension (systolic BP ≥160 mmHg) requires immediate drug treatment intensification 1
• High cardiovascular risk profile: 75 years old with diabetes mellitus (on metformin), dyslipidemia (on atorvastatin and ezetimibe), placing him in the high-risk category that warrants aggressive BP management 1
• Target BP for this patient: <130/80 mmHg given his diabetes and likely cardiovascular disease, though individualized for elderly based on frailty 1

Recommended Treatment Algorithm

Step 1: Add a Thiazide/Thiazide-Like Diuretic

The patient is already on maximum-dose amlodipine (10 mg), a dihydropyridine calcium channel blocker. The next step per International Society of Hypertension 2020 guidelines is to add a thiazide or thiazide-like diuretic 1. This creates a two-drug combination that has proven efficacy in reducing cardiovascular morbidity and mortality 1.

• Preferred options: chlorthalidone 12.5-25 mg daily or hydrochlorothiazide 12.5-25 mg daily 1
• This combination (CCB + diuretic) is evidence-based and well-tolerated 1

Step 2: Consider Adding an ACE Inhibitor or ARB

If BP remains uncontrolled after adding a diuretic (target: achieve control within 3 months), escalate to triple therapy by adding a renin-angiotensin system (RAS) blocker 1. Given his diabetes, an ACE inhibitor or ARB would provide additional renal protection 1.

• The three-drug combination should be: amlodipine + thiazide/thiazide-like diuretic + ACE inhibitor or ARB 1
• Single-pill combinations are strongly preferred to improve adherence 1, 2

Critical Considerations for This 75-Year-Old Patient

Age-Related Factors

• Target BP individualization: While the 2024 ESC guidelines recommend targeting systolic BP 120-129 mmHg in most adults, this must be individualized for elderly patients based on frailty 1
• The 2020 ISH guidelines suggest targeting BP <140/90 mmHg as a minimum, with individualization for elderly based on frailty 1
• Monitor for orthostatic hypotension and symptomatic hypotension, which are more common in elderly patients 1

Medication Review and Potential Interactions

Important drug considerations in this polypharmacy patient:

• Metformin: No significant interaction with antihypertensives, but monitor renal function as thiazide diuretics can affect kidney function 3
• Bupropion: Can increase blood pressure in some patients; monitor BP response after adding antihypertensive therapy 4
• Trospium and silodosin: Alpha-blockers like silodosin can lower BP; consider this additive effect 1
• Duloxetine: May increase BP or heart rate; monitor accordingly 4

Adherence Assessment

Before intensifying therapy, verify medication adherence 1. Non-adherence is a major cause of apparent treatment-resistant hypertension. Consider:

• Pill counts
• Pharmacy refill records
• Direct patient questioning about missed doses
• Home BP monitoring to confirm office readings 1

Monitoring Plan

• Recheck BP in 2-4 weeks after adding the diuretic 1
• Achieve target BP within 3 months of treatment intensification 1
• Monitor electrolytes (potassium, sodium) within 2-4 weeks of starting thiazide diuretic, especially given concurrent metformin use 1, 3
• Assess for adverse effects: peripheral edema (already on amlodipine 10 mg, which commonly causes this), dizziness, orthostatic symptoms 5, 6

Common Pitfalls to Avoid

• Do not delay treatment intensification: This patient has Grade 2 hypertension with diabetes—immediate action is required, not a "wait and see" approach 1
• Do not add a beta-blocker as second-line therapy unless there is a compelling indication (e.g., heart failure, post-MI, angina), as beta-blockers are not preferred second-line agents in this scenario 1
• Do not combine two RAS blockers (ACE inhibitor + ARB)—this is not recommended due to increased risk of adverse events without additional benefit 1
• Avoid therapeutic inertia: The patient is already on maximum-dose amlodipine; further dose escalation is not possible, so adding another agent is mandatory 1, 7

Alternative Consideration: Single-Pill Combination

If available and affordable, consider switching to a single-pill combination containing amlodipine + thiazide diuretic (or amlodipine + ARB + thiazide) to improve adherence in this patient already on 12 medications 1, 2, 8. Single-pill combinations have been shown to improve BP control rates and reduce cardiovascular events compared to free-dose combinations 2, 8.